MIMS Spotlight Series: Meet Anne-Marie Fors Connolly
Text written by Nóra Lehotai and Anne Marie Fors Connolly.
I had a chat with Anne-Marie Fors Connolly who joined MIMS as a Clinical Research Fellow in 2020. She is a true cosmopolitan, with Swedish and Danish nationalities and some Irish blood in her veins as well. She has lived in Denmark and Ireland before moving to Sweden, and now she is living with her husband, and they are hoping to soon welcome a dog in their lives.
Portrait picture of Anne-Marie Fors Connolly working in the lab. Credit: Mattias Petterson.
Can you tell us about your role at MIMS, what are you working on now?
I am a MIMS clinical research fellow. I finished my medical internship last year and I am currently specializing in Clinical Microbiology. Right now, I have several large projects ongoing in parallel ranging from in vitro studies in the laboratory, to clinical determinants of infectious disease outcome to large scale multi-register population studies. My research interests are focused on translational projects that are clinically relevant, since I like to feel I am contributing to society with the knowledge that is generated. My MIMS postdoc, Dr. Chloé Jacquet, is focusing on determining the cleaving factors of the endothelial glycocalyx during HFRS and COVID-19. My clinical project student, Hanna Jerndal, is visualizing the real-time thickness of the endothelial glycocalyx in COVID-19 patients. The principal research engineer Osvaldo Fonseca-Rodriguez is quantifying the risk of acute cardiovascular complications in all COVID-19 patients, together with Ioannis Katsoularis a medical doctor and PhD student. We have the help of a statistician, Erling Lundevaller, who works part-time in my group.